Selective Estrogen Receptor Modulators (SERMs) certainly are a cornerstone of pharmaceutical PCT interventions. They operate as competitive inhibitors at estrogen receptors in the hypothalamus whilst exhibiting tissue-selective agonist or antagonist properties through the system. SERMs are important in regulating post cycle estrogen manufacturing a